Catalyst Wire Dossier Catalyst Wire Dossier

Miricorilant

CORT118335 · Corcept Therapeutics
Drug timelines are a Plus or Pro feature.

9 regulatory and trial events tracked for Miricorilant, covering 2022-08-31 to 2026-04-21. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2b, Study Evaluating Miricorilant in Adult Patients With Nonalcoholic Steatohepatitis/Metabolic Dysfunction-Associated Steatohepatitis (MONARCH) [Phase 2]

See pricing